Lukang Pharma has launched two new products: Tulathromycin and Levodopa

Shandong Lukang Pharmaceutical Co., Ltd is a leading bio-pharmaceutical enterprise in China.

Established in 1966, Lukang Pharma engaged in bio-pharmaceutical business involves API, human drugs, veterinary drugs and biopesticides.

• API such as Tylosin and Spectinomycin series are widely praised worldwide
• Human drugs cover antibiotics, antidiabetic, antiviral drug, cardio-cerebrovascular drug, neurodegenerative drug and so on
• Biopesticide: Bacillus Thuringiensis, Spinosad (upcoming), Gibberellin
• Undertake CMO and CDMO business.

Why choose Lukang Pharma:

• Sound quality management system, 56 years consistent good quality
• Our workshops take the lead through the ISO 9001, ISO 14001, ISO 45001 system certification.
• Strict regulatory compliance and continual improvement
• High GMP management system such as U.S. cGMP, EU GMP and ICH Q7, as well as Chinese GMP, with all products certified by GMP
• Complete EHS system and high-tech facilities
• Strong production capacity, perfect equipment, advanced techniques, and complete quality supervision system
• 2.7 square kilometers production parks, with over 6000 employees
• API annual output: 20000+tonnes including Fermentation and Synthesis
• Human Drug annual output: 8+billion capsules, 2+billion powder-injections, 1.5+billion tablets
• 3 R&D centres and 5 pilot platforms throughout the country.

Products: 

Lukang Pharma has more than 500 types of products, which are of human, veterinary, and agricultural use.
Our new products: Tulathromycin (GMP+DMF)/ LEVODOPA (EP/USP).
Our complete product catalogue

For more information, please contact us at [email protected] or visit our website www.lkpc.com.